UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement | |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☐ | Definitive Proxy Statement | |
☒ | Definitive Additional Materials | |
☐ | Soliciting Material Pursuant to §240.14a-12 |
Genesco Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. | |||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) | Title of each class of securities to which transaction applies:
| |||
(2) | Aggregate number of securities to which transaction applies:
| |||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
(4) | Proposed maximum aggregate value of transaction:
| |||
(5) | Total fee paid:
| |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
(1) | Amount Previously Paid:
| |||
(2) | Form, Schedule or Registration Statement No.:
| |||
(3) | Filing Party:
| |||
(4) | Date Filed:
|
On July 6, 2021, Genesco Inc. (the Company) issued the following press release.
The press release was also posted by the Company to www.GenescoDrivingValue.com on July 6, 2021.
LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS GENESCO SHAREHOLDERS VOTE
FOR ALL NINE OF GENESCOS HIGHLY QUALIFIED DIRECTORS ON BLUE PROXY CARD
ISS advises Genescos shareholders to support all of the Boards nominees at upcoming Annual Meeting
Potential contribution of Legions nominees to Genescos Board would appear to be limited
according to ISS Report
NASHVILLE, Tenn. July 6, 2021 Genesco Inc. (NYSE: GCO) (Genesco or the Company) today announced that Institutional Shareholder Services (ISS), a leading independent provider of proxy research and vote recommendations to the institutional investment community, has recommended that Genesco shareholders vote the BLUE proxy card FOR ALL nine of the Companys director nominees at Genescos Annual Meeting of Shareholders to be held on July 20, 2021.
We are gratified that after a comprehensive review and analysis, ISS recommended that shareholders vote FOR ALL of Genescos highly qualified directors for reelection at our upcoming Annual Meeting, said Mimi Vaughn, Board Chair, President and CEO of Genesco. In its recommendation, ISS clearly recognizes that the skills and experience of our directors are essential to the continued execution of our footwear focused strategy, which is producing clear and positive results, and that Legions nominees would not bring anything new or additive to our Board. This endorsement from a leading proxy advisory firm underscores our strong belief that we have the right Board and strategy in place, and that we are well-positioned to succeed and enhance long-term shareholder value in a rapidly evolving retail landscape.
In making its recommendation that shareholders vote on the Companys BLUE proxy card FOR ALL NINE of Genescos highly qualified directors, ISS commented1:
| In light of GCOs recent board and management changes, and given that Legions nominees do not appear demonstrably superior to the directors whom they would replace, shareholders are advised to support the boards nominees at this annual meeting. |
| all four recently appointed members of the board appear to be appropriate additions, and the dissidents critique of interconnections among GCO board members is creative but unconvincing. |
| ...the immediate removal of the four longest-tenured directors standing for re-election does not appear necessary... |
| The dissidents cover the waterfront strategy lacks focus, and may present difficulties of digestion for shareholders |
ISS also highlighted that Legions nominees lack the relevant skills necessary to serve on Genescos Board, noting1:
| [Marjorie Bowen] provided very limited details about what she would like to accomplish in her second term on the board. |
1 | Permission to use quotations neither sought nor obtained from ISS and emphasis added by Genesco. |
| The companys concerns regarding [Dawn Robertsons] short-lived tenure at many companies seems valid and based on fact rather than opinion. |
| [Hobart Sichel] lacks public Board experience (which in this particular situation would seem essential, especially for a single dissident director), and the board has already considered him on their own volition and decided against advancing his candidacy. |
| [Margenett Moore-Roberts] lacks public Board experience and her skills of building an inclusive customer base and work force do not appear to be among the companys most urgent needs. |
| The potential contribution of Legions nominees to the board would therefore appear to be limited. |
Genesco Urges Shareholders to Vote FOR its Full Slate of Highly Qualified and
Experienced Director Nominees
Genesco continues to urge shareholders to protect the value of their investment by voting the BLUE proxy card today FOR all nine of the Companys highly qualified directors at the Companys Annual Meeting scheduled to be held on July 20, 2021. The Companys proxy statement and other important information related to its 2021 Annual Meeting of Shareholders can be found at www.GenescoDrivingValue.com.
PLEASE VOTE TODAY!
To make sure your vote is processed timely, we are encouraging all
shareholders to vote online or by telephone if possible
just follow the easy instructions on the enclosed BLUE proxy card.
You may also sign, date and return the enclosed BLUE proxy card.
If you have any questions or need help voting your BLUE proxy card,
please call the firm assisting us with the solicitation of proxies:
Innisfree
1 (877) 825-8772
(toll-free from the U.S. and Canada)
+1 (412) 232-3651
(from other locations)
REMEMBER:
Please simply discard any White proxy cards
you may receive from Legion, as voting on a White card,
even in protest, will revoke any previous proxy you submitted using
the BLUE proxy card. Only your latest-dated proxy counts.
About Genesco Inc.
Genesco Inc., a Nashville-based specialty retailer and branded company, sells footwear and accessories in more than 1,455 retail stores throughout the U.S., Canada, the United Kingdom and the Republic of Ireland, principally under the names Journeys, Journeys Kidz, Little Burgundy, Schuh, Schuh Kids, Johnston & Murphy, and on internet websites www.journeys.com, www.journeyskidz.com, www.journeys.ca, www.littleburgundyshoes.com, www.schuh.co.uk, www.johnstonmurphy.com, www.johnstonmurphy.ca, www.nashvilleshoewarehouse.com, and www.dockersshoes.com. In addition, Genesco sells footwear at wholesale under its Johnston & Murphy brand, the licensed Levis brand, the licensed Dockers brand, the licensed Bass brand, and other brands. For more information on Genesco and its operating divisions, please visit www.genesco.com.
Forward-Looking Statements
This release contains forward-looking statements, including those regarding the performance outlook for the Company and all other statements not addressing solely historical facts or present conditions. Forward- looking statements are usually identified by or are associated with such words as intend, expect, believe, should, anticipate, optimistic and similar terminology. Actual results could vary materially from the expectations reflected in these statements. A number of factors could cause differences. These include adjustments to projections reflected in forward-looking statements, including those resulting from the effects of COVID-19 on the Companys business, including COVID-19 case spikes in locations in which the Company operates, the roll-out of COVID-19 vaccines and the publics acceptance of the vaccines, additional stores closures due to COVID-19, the timing of the re-opening of our stores, the timing of in-person back-to-work and back-to-school and sales with respect thereto, weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements, and limitations on the Companys ability to adequately staff and operate stores. Differences from expectations could also result from stores closures and effects on the business as a result of civil disturbances; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; the imposition of tariffs on product imported by the Company or its vendors as well as the ability and costs to move production of products in response to tariffs; the Companys ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of COVID-19; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs, and other factors affecting the cost of products; the effects of the British decision to exit the European Union and other sources of market weakness in the U.K. and Republic of Ireland; the effectiveness of the Companys omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressure in the U.S. and the U.K.; weakness in the consumer economy and retail industry; competition and fashion trends in the Companys markets; risks related to the potential for terrorist events; risks related to public health and safety events; changes in buying patterns by significant wholesale customers; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include the ability to renew leases in existing stores and control or lower occupancy costs, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; the Companys ability to realize anticipated cost savings, including rent savings; the Companys ability to achieve expected digital gains and gain market share; deterioration in the performance of individual businesses or of the Companys market value relative to its book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for the Companys shares or for the retail sector in general; costs and reputational harm as a result of
disruptions in the Companys business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems; the Companys ability to realize any anticipated tax benefits; and the cost and outcome of litigation, investigations and environmental matters involving the Company, and the impact of actions initiated by activist shareholders. Additional factors are cited in the Risk Factors, Legal Proceedings and Managements Discussion and Analysis of Financial Condition and Results of Operations sections of, and elsewhere in, the Companys SEC filings, copies of which may be obtained from the SEC website, www.sec.gov, or by contacting the investor relations department of Genesco via the Companys website, www.genesco.com. Many of the factors that will determine the outcome of the subject matter of this release are beyond Genescos ability to control or predict. Genesco undertakes no obligation to release publicly the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Forward-looking statements reflect the expectations of the Company at the time they are made. The Company disclaims any obligation to update such statements.
Important Additional Information and Where to Find It
Genesco has filed a definitive proxy statement (the Proxy Statement) and accompanying proxy card in connection with the solicitation of proxies for the 2021 annual meeting of Genesco shareholders (the Annual Meeting). INVESTORS AND SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ THE PROXY STATEMENT AND ACCOMPANYING PROXY CARD AND OTHER DOCUMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (THE SEC) CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders may obtain the Proxy Statement, any amendments or supplements to the Proxy Statement and other documents filed by Genesco with the SEC for no charge at the SECs website at www.sec.gov. Copies will also be available at no charge in the Investors section of Genescos corporate website at www.genesco.com.
Participants in the Solicitation
Genesco, its directors and certain of its executive officers may be deemed to be participants in the solicitation of proxies from Genesco shareholders in connection with the matters to be considered at the Annual Meeting. Information regarding the names of Genescos directors and executive officers and certain other individuals and their respective interests in Genesco by security holdings or otherwise is set forth in the Annual Report on Form 10-K of Genesco for the fiscal year ended January 30, 2021, and in the Proxy Statement. To the extent holdings of such participants in Genescos securities have changed since the amounts described in the Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC.
###
Media Contacts
Claire S. McCall
cmccall@genesco.com
(615) 308-2483
Or
Jared Levy / Danya Al-Qattan
Sard Verbinnen & Co
Genesco-SVC@sardverb.com
Investor Contacts
Tom George
tgeorge@genesco.com
(615) 367-7465
Or
David Slater
dslater@genesco.com
(615) 367-7604